Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Rapid Critical Metals: Visit us at PDAC 2026... February 20, 2026 Chris Marcus: Silver Supply Crunch Not Over, Price... November 13, 2025 Silver47 Announces $14 Million Brokered LIFE Financing August 26, 2025 Skyharbour Closes Acquisition to Consolidate 100% Interest in... December 17, 2025 Altech Batteries LtdSilumina Anodes Assessed by Major Battery... November 24, 2025 Québec Communities Vote “No” to La Loutre Graphite... September 6, 2025 Syntheia Announces Closing of the Final Tranche of... October 7, 2025 Editor’s Picks: Gold Sets New Price Record, Silver... September 6, 2025 Offer Booklet – Non-Renounceable Entitlement Offer June 6, 2025 Crypto Market Update: Sector Recovers Heading into the... November 10, 2025